Global Liraglutide Competitive Landscape Professional Research Report 2025
Description
Global Liraglutide Competitive Landscape Professional Research Report 2025
Research Summary
Liraglutide is a medication that belongs to the class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 agonists). It is primarily used to manage blood sugar levels in adults with type 2 diabetes. Liraglutide works by mimicking the effects of a natural hormone called glucagon-like peptide-1, which helps regulate blood sugar levels by stimulating insulin secretion, reducing appetite, and slowing down the emptying of the stomach. In addition to its glucose-lowering effects, liraglutide has also been approved for weight management in individuals who are obese or overweight and have certain weight-related medical conditions. It is administered as a once-daily injection and has demonstrated effectiveness in improving glycemic control and promoting weight loss in clinical studies.
According to DIResearch's in-depth investigation and research, the global Liraglutide market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Liraglutide. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Liraglutide market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Liraglutide market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Liraglutide industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Liraglutide Include:
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Liraglutide Product Segment Include:
Liraglutide Pills
Liraglutide Injection
Liraglutide Product Application Include:
Hospital
Drug Store
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Liraglutide Capacity and Production Analysis
Chapter 3: Global Liraglutide Industry PESTEL Analysis
Chapter 4: Global Liraglutide Industry Porter's Five Forces Analysis
Chapter 5: Global Liraglutide Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 6: Global Liraglutide Market Size and Forecast by Type and Application Analysis
Chapter 7: North America Liraglutide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: Europe Liraglutide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: China Liraglutide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: APAC (Excl. China) Liraglutide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Latin America Liraglutide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Middle East and Africa Liraglutide Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 13: Global Liraglutide Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 16: Research Findings and Conclusion
Chapter 17: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Liraglutide Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Liraglutide Product by Type
- 1.2.1 Liraglutide Pills
- 1.2.2 Liraglutide Injection
- 1.3 Liraglutide Product by Application
- 1.3.1 Hospital
- 1.3.2 Drug Store
- 1.4 Global Liraglutide Market Revenue and Sales Analysis
- 1.4.1 Global Liraglutide Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Liraglutide Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Liraglutide Market Sales Price Trend Analysis (2020-2032)
- 1.5 Liraglutide Industry Trends and Innovation
- 1.5.1 Liraglutide Industry Trends and Innovation
- 1.5.2 Liraglutide Market Drivers and Challenges
- 2 Global Liraglutide Capacity and Production Analysis
- 2.1 Global Liraglutide Capacity, Production and Utilization (2020-2032)
- 2.2 Global Liraglutide Production Growth Trend by Region: 2024 VS 2025 VS 2030
- 2.3 Global Liraglutide Production by Region
- 2.3.1 Global Liraglutide Production by Region (2020-2025)
- 2.3.2 Global Liraglutide Production Forecast by Region (2026-2032)
- 2.3.3 Global Liraglutide Production Market Share by Region (2020-2032)
- 3 Liraglutide Market PESTEL Analysis
- 3.1 Political Factors Analysis
- 3.2 Economic Factors Analysis
- 3.3 Social Factors Analysis
- 3.4 Technological Factors Analysis
- 3.5 Environmental Factors Analysis
- 3.6 Legal Factors Analysis
- 4 Liraglutide Market Porter's Five Forces Analysis
- 4.1 Competitive Rivalry
- 4.2 Threat of New Entrants
- 4.3 Bargaining Power of Suppliers
- 4.4 Bargaining Power of Buyers
- 4.5 Threat of Substitutes
- 5 Global Liraglutide Market Analysis by Regions
- 5.1 Liraglutide Overall Market: 2024 VS 2025 VS 2032
- 5.2 Global Liraglutide Revenue and Forecast Analysis (2020-2032)
- 5.2.1 Global Liraglutide Revenue and Market Share by Region (2020-2025)
- 5.2.2 Global Liraglutide Revenue and Market Forecast by Region (2026-2032)
- 5.3 Global Liraglutide Sales and Forecast Analysis (2020-2032)
- 5.3.1 Global Liraglutide Sales and Market Share by Region (2020-2025)
- 5.3.2 Global Liraglutide Sales and Market Forecast by Region (2026-2032)
- 5.4 Global Liraglutide Sales Price Trend Analysis (2020-2032)
- 6 Global Liraglutide Market Size by Type and Application
- 6.1 Global Liraglutide Market Size by Type
- 6.1.1 Global Liraglutide Revenue and Forecast Analysis by Type (2020-2032)
- 6.1.2 Global Liraglutide Sales and Forecast Analysis by Type (2020-2032)
- 6.2 Global Liraglutide Market Size by Application
- 6.2.1 Global Liraglutide Revenue and Forecast Analysis by Application (2020-2032)
- 6.2.2 Global Liraglutide Sales and Forecast Analysis by Application (2020-2032)
- 7 North America
- 7.1 North America Liraglutide Market Size and Growth Rate Analysis (2020-2032)
- 7.2 North America Key Manufacturers Analysis
- 7.3 North America Liraglutide Market Size by Type
- 7.3.1 North America Liraglutide Sales by Type (2020-2032)
- 7.3.2 North America Liraglutide Revenue by Type (2020-2032)
- 7.4 North America Liraglutide Market Size by Application
- 7.4.1 North America Liraglutide Sales by Application (2020-2032)
- 7.4.2 North America Liraglutide Revenue by Application (2020-2032)
- 7.5 North America Liraglutide Market Size by Country
- 7.5.1 US
- 7.5.2 Canada
- 8 Europe
- 8.1 Europe Liraglutide Market Size and Growth Rate Analysis (2020-2032)
- 8.2 Europe Key Manufacturers Analysis
- 8.3 Europe Liraglutide Market Size by Type
- 8.3.1 Europe Liraglutide Sales by Type (2020-2032)
- 8.3.2 Europe Liraglutide Revenue by Type (2020-2032)
- 8.4 Europe Liraglutide Market Size by Application
- 8.4.1 Europe Liraglutide Sales by Application (2020-2032)
- 8.4.2 Europe Liraglutide Revenue by Application (2020-2032)
- 8.5 Europe Liraglutide Market Size by Country
- 8.5.1 Germany
- 8.5.2 France
- 8.5.3 United Kingdom
- 8.5.4 Italy
- 8.5.5 Spain
- 8.5.6 Benelux
- 9 China
- 9.1 China Liraglutide Market Size and Growth Rate Analysis (2020-2032)
- 9.2 China Key Manufacturers Analysis
- 9.3 China Liraglutide Market Size by Type
- 9.3.1 China Liraglutide Sales by Type (2020-2032)
- 9.3.2 China Liraglutide Revenue by Type (2020-2032)
- 9.4 China Liraglutide Market Size by Application
- 9.4.1 China Liraglutide Sales by Application (2020-2032)
- 9.4.2 China Liraglutide Revenue by Application (2020-2032)
- 10 APAC (excl. China)
- 10.1 APAC (excl. China) Liraglutide Market Size and Growth Rate Analysis (2020-2032)
- 10.2 APAC (excl. China) Key Manufacturers Analysis
- 10.3 APAC (excl. China) Liraglutide Market Size by Type
- 10.3.1 APAC (excl. China) Liraglutide Sales by Type (2020-2032)
- 10.3.2 APAC (excl. China) Liraglutide Revenue by Type (2020-2032)
- 10.4 APAC (excl. China) Liraglutide Market Size by Application
- 10.4.1 APAC (excl. China) Liraglutide Sales by Application (2020-2032)
- 10.4.2 APAC (excl. China) Liraglutide Revenue by Application (2020-2032)
- 10.5 APAC (excl. China) Liraglutide Market Size by Country
- 10.5.1 Japan
- 10.5.2 South Korea
- 10.5.3 India
- 10.5.4 Australia
- 10.5.5 Southeast Asia
- 11 Latin America
- 11.1 Latin America Liraglutide Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Latin America Key Manufacturers Analysis
- 1`.3 Latin America Liraglutide Market Size by Type
- 11.3.1 Latin America Liraglutide Sales by Type (2020-2032)
- 11.3.2 Latin America Liraglutide Revenue by Type (2020-2032)
- 11.4 Latin America Liraglutide Market Size by Application
- 11.4.1 Latin America Liraglutide Sales by Application (2020-2032)
- 11.4.2 Latin America Liraglutide Revenue by Application (2020-2032)
- 11.5 Latin America Liraglutide Market Size by Country
- 11.6 Latin America Liraglutide Market Size by Country
- 11.6.1 Mexico
- 11.6.2 Brazil
- 12 Middle East & Africa
- 12.1 Middle East & Africa Liraglutide Market Size and Growth Rate Analysis (2020-2032)
- 12.2 Middle East & Africa Key Manufacturers Analysis
- 12.3 Middle East & Africa Liraglutide Market Size by Type
- 12.3.1 Middle East & Africa Liraglutide Sales by Type (2020-2032)
- 12.3.2 Middle East & Africa Liraglutide Revenue by Type (2020-2032)
- 12.4 Middle East & Africa Liraglutide Market Size by Application
- 12.4.1 Middle East & Africa Liraglutide Sales by Application (2020-2032)
- 12.4.2 Middle East & Africa Liraglutide Revenue by Application (2020-2032)
- 12.5 Middle East Liraglutide Market Size by Country
- 12.5.1 Saudi Arabia
- 12.5.2 South Africa
- 13 Competition by Manufacturers
- 13.1 Global Liraglutide Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 13.1.1 Global Liraglutide Market Sales by Key Manufacturers (2021-2025)
- 13.1.2 Global Liraglutide Market Revenue by Key Manufacturers (2021-2025)
- 13.1.3 Global Liraglutide Average Sales Price by Manufacturers (2021-2025)
- 13.2 Liraglutide Competitive Landscape Analysis and Market Dynamic
- 13.2.1 Liraglutide Competitive Landscape Analysis
- 13.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 13.2.3 Market Dynamic
- 14 Key Companies Analysis
- 14.1 HEC Pharm
- 14.1.1 HEC Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.1.2 HEC Pharm Liraglutide Product Portfolio
- 14.1.3 HEC Pharm Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.2 Bachem
- 14.2.1 Bachem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.2.2 Bachem Liraglutide Product Portfolio
- 14.2.3 Bachem Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.3 Bharat Pharmaceuticals
- 14.3.1 Bharat Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.3.2 Bharat Pharmaceuticals Liraglutide Product Portfolio
- 14.3.3 Bharat Pharmaceuticals Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.4 Kingpep Biotechnology
- 14.4.1 Kingpep Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.4.2 Kingpep Biotechnology Liraglutide Product Portfolio
- 14.4.3 Kingpep Biotechnology Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.5 Shenzhen JYMed Technology
- 14.5.1 Shenzhen JYMed Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.5.2 Shenzhen JYMed Technology Liraglutide Product Portfolio
- 14.5.3 Shenzhen JYMed Technology Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.6 Wuxi Asiapeptide
- 14.6.1 Wuxi Asiapeptide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.6.2 Wuxi Asiapeptide Liraglutide Product Portfolio
- 14.6.3 Wuxi Asiapeptide Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.7 AmbioPharm
- 14.7.1 AmbioPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.7.2 AmbioPharm Liraglutide Product Portfolio
- 14.7.3 AmbioPharm Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 15 Industry Chain Analysis
- 15.1 Liraglutide Industry Chain Analysis
- 15.2 Liraglutide Industry Raw Material and Suppliers Analysis
- 15.2.1 Liraglutide Key Raw Material Supply Analysis
- 15.2.2 Raw Material Suppliers and Contact Information
- 15.3 Liraglutide Typical Downstream Customers
- 15.4 Liraglutide Sales Channel Analysis
- 16 Research Findings and Conclusion
- 17 Methodology and Data Source
- 17.1 Methodology/Research Approach
- 17.2 Research Scope
- 17.3 Benchmarks and Assumptions
- 17.4 Date Source
- 17.4.1 Primary Sources
- 17.4.2 Secondary Sources
- 17.5 Data Cross Validation
- 17.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
